Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01892046
Title Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Esanex Inc.
Indications

lung non-small cell carcinoma

lung small cell carcinoma

Therapies

Carboplatin

SNX-5422

Paclitaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Medical Center Washington, D.C. District of Columbia 20007 United States Details
Georgia Regents University Cancer Center Augusta Georgia 30912 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field